Vitiligo is a medical condition, not a cosmetic one — yet federal health plans treat it inconsistently, with some covering FDA-approved treatments and others excluding them outright.
DCAN joined patient advocates in calling for consistent guidelines across federal programs, so that a diagnosis means the same access to care regardless of which plan a patient happens to have.
This is sample article copy — replace it with the full text or a summary and link from the site admin.
